Shuttle Pharmaceuticals Competitors and Similar CompaniesClear all

Shuttle Pharmaceuticals's competitors and similar companies include Halozyme Therapeutics and Deciphera Pharmaceuticals.

	Shuttle Pharmaceuticals Shuttle Pharmaceuticals is a pharmaceutical company leveraging its proprietary technology to develop therapies that are designed to cure cancer.	Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Founding Date	Founding Date 2012	Founding Date 1998	Founding Date 2003
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Rockville, US HQ	Locations San Diego, US HQ	Locations Waltham, US HQ Lawrence, US
Employees	Employees 5	Employees 373157% increase	Employees 35037% increase
Valuation ($)	Valuation ($) 5.3 m	Valuation ($) 6.4 b	Valuation ($) 2.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.4b (FY, 2025)	Revenue (est.) $163.4m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods $228.8m (FY, 2025)	Cost of goods $3.7m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit $1.2b (FY, 2025)	Gross profit $159.6m (FY, 2023)
Net income	Net income ($11.7m) (FY, 2025)	Net income $316.9m (FY, 2025)	Net income ($194.9m) (FY, 2023)
Operating ⚠
Patent Applications	Patent Applications N/A	Patent Applications 50 (FY, 2020)	Patent Applications 49 (Aug, 2017)
Patents (US)	Patents (US) N/A	Patents (US) 43 (FY, 2020)	Patents (US) 11 (Aug, 2017)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 171.9m	Total funding raised $ 714m